ストックスクリーナーアプリを入手
45.28
1.18%
0.53
アフターアワーズ：
46.62
1.34
+2.96%
前日終値:
$44.75
開ける：
$44.3
24時間の取引高:
1.39M
Relative Volume:
0.82
時価総額：
$5.88B
収益：
-
当期純損益:
$-507.65M
株価収益率:
-9.8435
EPS:
-4.6
ネットキャッシュフロー:
$-616.24M
1週間 パフォーマンス:
+7.22%
1か月 パフォーマンス:
+25.71%
6か月 パフォーマンス:
+26.34%
1年 パフォーマンス:
-57.42%
1日の値動き範囲:
$43.78
$45.36
1週間の範囲:
$42.30
$45.69
52週間の値動き範囲:
$27.66
$116.00
Vaxcyte Inc Stock (PCVX) Company Profile
名前
Vaxcyte Inc
セクター
電話
650-837-0111
住所
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
PCVX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PCVX
Vaxcyte Inc
|
45.28 | 5.81B | 0 | -507.65M | -616.24M | -4.60 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Vaxcyte Inc Stock (PCVX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-12 | 開始されました | Goldman | Neutral |
| 2025-04-22 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-12-20 | 開始されました | Goldman | Buy |
| 2023-12-07 | 開始されました | Mizuho | Buy |
| 2023-04-18 | 開始されました | TD Cowen | Outperform |
| 2023-01-03 | 繰り返されました | Needham | Buy |
| 2022-12-15 | 開始されました | Guggenheim | Buy |
| 2022-11-17 | 開始されました | BTIG Research | Buy |
| 2021-12-29 | 再開されました | Jefferies | Buy |
| 2021-06-24 | 再開されました | Jefferies | Buy |
| 2020-07-07 | 開始されました | BofA Securities | Buy |
| 2020-07-07 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-07-07 | 開始されました | Needham | Buy |
すべてを表示
Vaxcyte Inc (PCVX) 最新ニュース
Does Vaxcyte Inc. show high probability of rebound2025 Analyst Calls & Long-Term Safe Investment Plans - newser.com
Has Vaxcyte Inc. found a price floorJuly 2025 Sector Moves & Stepwise Entry and Exit Trade Signals - newser.com
Should you wait for a breakout in Vaxcyte Inc.Inflation Watch & Weekly Momentum Stock Picks - newser.com
What margin trends mean for Vaxcyte Inc. stockJuly 2025 Sector Moves & Stepwise Entry and Exit Trade Signals - newser.com
Quantitative breakdown of Vaxcyte Inc. recent moveShort Setup & Smart Swing Trading Alerts - newser.com
Will Vaxcyte Inc. stock outperform Nasdaq indexJuly 2025 EndofMonth & Capital Protection Trading Alerts - newser.com
Using data tools to time your Vaxcyte Inc. exitBond Market & Fast Entry and Exit Trade Plans - newser.com
Will Vaxcyte Inc. stock benefit from commodity pricesPortfolio Profit Report & Verified Swing Trading Watchlists - newser.com
Is Vaxcyte Inc. (5VA) stock protected from inflationPortfolio Risk Summary & Fast Entry Momentum Alerts - newser.com
Can Vaxcyte Inc. (5VA) stock attract analyst upgradesJuly 2025 Short Interest & Weekly Top Gainers Alerts - newser.com
Gillette India The best an Investor can getVolume Spike Alerts & Ride the Wave of Market-Beating Growth - earlytimes.in
Is Vaxcyte Inc a good long term investmentPrice Volatility Patterns & Superior Capital Appreciation - earlytimes.in
What moving averages say about Vaxcyte Inc.July 2025 PostEarnings & Step-by-Step Swing Trade Plans - newser.com
Is Vaxcyte Inc. stock poised for growthJuly 2025 Market Mood & Proven Capital Preservation Methods - newser.com
Vaxcyte (PCVX) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Will Vaxcyte Inc. benefit from macro trendsJuly 2025 Drop Watch & Intraday High Probability Alerts - newser.com
When is the best time to exit Vaxcyte Inc.July 2025 Weekly Recap & Reliable Intraday Trade Plans - newser.com
Identifying reversal signals in Vaxcyte Inc.July 2025 Action & Weekly Watchlist for Hot Stocks - newser.com
Market Wrap: What margin trends mean for Vaxcyte Inc. stockJuly 2025 Outlook & Risk Adjusted Buy/Sell Alerts - Fundação Cultural do Pará
Is Vaxcyte Inc. stock supported by innovation pipelineQuarterly Growth Report & Free Weekly Chart Analysis and Trade Guides - Fundação Cultural do Pará
Vaxcyte’s VAX-31 Study: A Potential Game-Changer in Infant Vaccination - TipRanks
Is Vaxcyte Inc. stock near bottom after declineEarnings Growth Summary & Trade Opportunity Analysis Reports - Fundação Cultural do Pará
Vaxcyte, Inc. (PCVX) Investor Outlook: Unpacking a 132% Potential Upside in the Biotech Space - DirectorsTalk Interviews
Risk adjusted return profile for Vaxcyte Inc. analyzed2025 Top Decliners & Entry Point Confirmation Alerts - newser.com
Will Vaxcyte's VAX-24 Infant Phase 2 Dose-Finding Study Data Revive Investor Interest? - RTTNews
Vaxcyte Inc (PCVX) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):